LI has seen a 60% price rise since significantly beating the earnings estimates of the analysts.
LI competes with TSLA and NIO primarily in Chinese and perhaps a little in Scandinavia. It
does not import to North America. The 2H chart shows price rising consistently in a channel
between the first and second standard deviation lines above the mean anchored VWAP
demonstrating trend persistence and momentum. The zero-lag MACD shows a line cross
at the zero horizontal line and rising as confirmation of bullish momentum. I see $40
as a reasonable target at the level of the 3rd upper standard deviation lines. With the
next earnings report due August 21st, I will take a long trade of ten call options striking
$38.00 expiring 8/18/23. On the last trading day, this option had a low of $1.75 and
a high of $1.90 for an intraday rise of about 8%. The contracts will cost about $1900.
I am expecting about a 3% average rise compounded over 30 trading days or 250%
return on the trade.
LI competes with TSLA and NIO primarily in Chinese and perhaps a little in Scandinavia. It
does not import to North America. The 2H chart shows price rising consistently in a channel
between the first and second standard deviation lines above the mean anchored VWAP
demonstrating trend persistence and momentum. The zero-lag MACD shows a line cross
at the zero horizontal line and rising as confirmation of bullish momentum. I see $40
as a reasonable target at the level of the 3rd upper standard deviation lines. With the
next earnings report due August 21st, I will take a long trade of ten call options striking
$38.00 expiring 8/18/23. On the last trading day, this option had a low of $1.75 and
a high of $1.90 for an intraday rise of about 8%. The contracts will cost about $1900.
I am expecting about a 3% average rise compounded over 30 trading days or 250%
return on the trade.
Trade active
LI moved up nothing substantial ; holding all contracts no changes.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.